Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4889)
All Articles published online
|
Publishing Process of This Article
|
Dec 26, 2019 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang G, Ning FY, Wang JH, Yan HM, Kong HW, Zhang YT, Shen Q. Expression of interleukin-32 in bone marrow of patients with myeloma and its prognostic significance. World J Clin Cases 2019; 7(24): 4234-4244 [PMID: 31911904 DOI: 10.12998/wjcc.v7.i24.4234] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8470/full/v7/i24/4234.htm |
| Number | Citing Articles |
| 1 |
Federica Plano, Anna Maria Corsale, Emilia Gigliotta, Giulia Camarda, Candida Vullo, Marta Di Simone, Mojtaba Shekarkar Azgomi, Maria Speciale, Melania Carlisi, Nadia Caccamo, Francesco Dieli, Serena Meraviglia, Sergio Siragusa, Cirino Botta. Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again. Hematology Reports 2023; 15(1): 23 doi: 10.3390/hematolrep15010004
|
| 2 |
Dominika Bębnowska, Rafał Hrynkiewicz, Ewelina Grywalska, Marcin Pasiarski, Barbara Sosnowska-Pasiarska, Iwona Smarz-Widelska, Stanisław Góźdź, Jacek Roliński, Paulina Niedźwiedzka-Rystwej. Immunological Prognostic Factors in Multiple Myeloma. International Journal of Molecular Sciences 2021; 22(7): 3587 doi: 10.3390/ijms22073587
|
| 3 |
Xinling Liu, Jiaqiu Li, Zhanju Wang, Jie Meng, Aihong Wang, Xiaofei Zhao, Qilu Xu, Zhen Cai, Zhenbo Hu. KDM2A Targets PFKFB3 for Ubiquitylation to Inhibit the Proliferation and Angiogenesis of Multiple Myeloma Cells. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.653788
|